The latest announcement is out from Imagion Biosystems Ltd. ( (AU:IBX) ).
Imagion Biosystems has announced that its 2025 Annual General Meeting (AGM) will be held on May 30, 2025, with the deadline for director nominations set for April 8, 2025. This announcement is a procedural update, ensuring stakeholders are informed about the upcoming AGM and the process for director nominations, reflecting the company’s commitment to transparency and governance.
More about Imagion Biosystems Ltd.
Imagion Biosystems is a company focused on advancing healthcare through innovative diagnostic technologies. It specializes in developing non-radioactive, precision molecular imaging technology that combines biotechnology and nanotechnology to enable earlier and more specific detection of cancer and other diseases.
YTD Price Performance: -20.0%
Average Trading Volume: 1,082,993
Technical Sentiment Signal: Buy
Current Market Cap: A$3.22M
For a thorough assessment of IBX stock, go to TipRanks’ Stock Analysis page.